Shaq might be Sanofi's newest pitchman
January 15 2010
Sanofi-Aventis is betting its $1.9-billion purchase of Chattem can give it a US marketing platform for future Rx-to-OTC switch brands.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.